TrialJournal for immunotherapy of cancer2026

Clinical outcomes and spatial transcriptomic profiles of CD19/20 CAR-T therapy in relapsed or refractory B-cell non-Hodgkin's lymphoma.

Lixin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.